BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28488841)

  • 1. Catastrophic antiphospholipid syndrome: an update.
    Espinosa G; Rodríguez-Pintó I; Cervera R
    Panminerva Med; 2017 Sep; 59(3):254-268. PubMed ID: 28488841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
    Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G;
    Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catastrophic antiphospholipid syndrome: The current management approach.
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):239-249. PubMed ID: 27886797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of refractory cases of catastrophic antiphospholipid syndrome.
    Espinosa G; Berman H; Cervera R
    Autoimmun Rev; 2011 Sep; 10(11):664-8. PubMed ID: 21569863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
    Espinosa G; Bucciarelli S; Asherson RA; Cervera R
    Semin Thromb Hemost; 2008 Apr; 34(3):290-4. PubMed ID: 18720310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
    Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
    J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catastrophic antiphospholipid syndrome].
    Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
    Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review.
    Cervera R; Rodríguez-Pintó I; Espinosa G
    J Autoimmun; 2018 Aug; 92():1-11. PubMed ID: 29779928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of catastrophic antiphospholipid syndrome.
    Kazzaz NM; McCune WJ; Knight JS
    Curr Opin Rheumatol; 2016 May; 28(3):218-27. PubMed ID: 26927441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry".
    López-Benjume B; Rodríguez-Pintó I; Amigo MC; Erkan D; Shoenfeld Y; Cervera R; Espinosa G;
    Autoimmun Rev; 2022 Apr; 21(4):103055. PubMed ID: 35085802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus.
    González-García A; López-Rodríguez M; Redondo S; Patier JL; Masso P; Tenorio M; Fajardo GS; Sarhane Y; Lacalzada MM; Manzano L
    Lupus; 2020 Aug; 29(9):1126-1129. PubMed ID: 32517572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.
    Ruffatti A; De Silvestro G; Marson P; Tonello M; Calligaro A; Favaro M; Del Ross T; Hoxha A; Mattia E; Pengo V
    J Autoimmun; 2018 Sep; 93():124-130. PubMed ID: 30146007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.
    Rymarz A; Niemczyk S
    BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.
    Bucciarelli S; Espinosa G; Cervera R
    Lupus; 2009 Sep; 18(10):905-12. PubMed ID: 19671791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease.
    Unlu O; Erkan D
    Annu Rev Med; 2017 Jan; 68():287-296. PubMed ID: 28099080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.
    Rangel ML; Alghamdi I; Contreras G; Harrington T; Thomas DB; Barisoni L; Andrews D; Wolf M; Asif A; Nayer A
    Lupus; 2013 Jul; 22(8):855-64. PubMed ID: 23722230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of catastrophic antiphospholipid syndrome.
    Carmi O; Berla M; Shoenfeld Y; Levy Y
    Expert Rev Hematol; 2017 Apr; 10(4):365-374. PubMed ID: 28277850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange in catastrophic antiphospholipid syndrome.
    Rodríguez-Pintó I; Lozano M; Cid J; Espinosa G; Cervera R
    Presse Med; 2019 Nov; 48(11 Pt 2):347-353. PubMed ID: 31694791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catastrophic antiphospholipid syndrome.
    Cervera R; Asherson RA; Font J
    Rheum Dis Clin North Am; 2006 Aug; 32(3):575-90. PubMed ID: 16880085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.